Literature DB >> 26724529

ApoE knockout rabbits: A novel model for the study of human hyperlipidemia.

Manabu Niimi1, Dongshan Yang2, Shuji Kitajima3, Bo Ning1, Chuan Wang1, Shen Li1, Enqi Liu4, Jifeng Zhang2, Y Eugene Chen2, Jianglin Fan5.   

Abstract

OBJECTIVE: Rabbits are one of the best animal models for the study of hyperlipidemia and atherosclerosis. Although many transgenic rabbits have been created, the development of gene knockout (KO) rabbits has been impossible due to the lack of rabbit embryonic stem cells. We along with others recently generated KO rabbits using genome editing techniques. In the current study, we characterized the lipoprotein profiles of apoE KO rabbits on both chow and cholesterol diets and investigated their susceptibility to a diet-induced atherosclerosis. APPROACH AND
RESULTS: We analyzed plasma lipids and lipoproteins of apoE KO rabbits and compared them with those of wild-type rabbits. On a chow diet, homozygous (but not heterozygous) apoE KO rabbits showed mild hyperlipidemia and, when challenged with a cholesterol diet, they showed greater susceptibility to diet-induced hyperlipidemia than did the wild-type rabbits and their plasma total cholesterol levels were remarkably increased (1070 ± 61 mg/dL in apoE KO vs. 169 ± 79 mg/dL in the wild type, p < 0.001). Hyperlipidemia in apoE KO rabbits was caused by elevated remnant lipoproteins. Interestingly, increased remnant lipoproteins in apoE KO rabbits were predominated by apoB-48 and rich in both apoA-I and apoA-IV contents. Furthermore, apoE KO rabbits developed greater aortic atherosclerosis than wild-type rabbits when fed with a cholesterol diet for 10 weeks.
CONCLUSIONS: To our knowledge, this is the first report of generating KO rabbits for the study of lipid and lipoprotein metabolism. ApoE KO rabbits should be a useful model for the study of human hyperlipidemia and atherosclerosis.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Apolipoprotein E; Genome editing; Hyperlipidemia; Knockout; Lipoprotein metabolism; Rabbit

Mesh:

Substances:

Year:  2015        PMID: 26724529     DOI: 10.1016/j.atherosclerosis.2015.12.002

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  25 in total

Review 1.  Genome editing in cardiovascular diseases.

Authors:  Alanna Strong; Kiran Musunuru
Journal:  Nat Rev Cardiol       Date:  2016-09-09       Impact factor: 32.419

Review 2.  Hyperlipidaemia and cardioprotection: Animal models for translational studies.

Authors:  Ioanna Andreadou; Rainer Schulz; Lina Badimon; Adriana Adameová; Petra Kleinbongard; Sandrine Lecour; Panagiota-Efstathia Nikolaou; Ines Falcão-Pires; Gemma Vilahur; Nicholas Woudberg; Gerd Heusch; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2020-01-17       Impact factor: 8.739

Review 3.  Treatment of Dyslipidemia Using CRISPR/Cas9 Genome Editing.

Authors:  Alexandra C Chadwick; Kiran Musunuru
Journal:  Curr Atheroscler Rep       Date:  2017-07       Impact factor: 5.113

Review 4.  Genome Editing for the Study of Cardiovascular Diseases.

Authors:  Alexandra C Chadwick; Kiran Musunuru
Journal:  Curr Cardiol Rep       Date:  2017-03       Impact factor: 2.931

Review 5.  Dog models of human atherosclerotic cardiovascular diseases.

Authors:  Hui Zhao; Enqi Liu; Yong Q Zhang
Journal:  Mamm Genome       Date:  2022-10-15       Impact factor: 3.224

Review 6.  Rabbit models of human diseases for diagnostics and therapeutics development.

Authors:  Rose G Mage; Pedro J Esteves; Christoph Rader
Journal:  Dev Comp Immunol       Date:  2018-10-16       Impact factor: 3.636

Review 7.  Integration of Transformative Platforms for the Discovery of Causative Genes in Cardiovascular Diseases.

Authors:  Haocheng Lu; Jifeng Zhang; Y Eugene Chen; Minerva T Garcia-Barrio
Journal:  Cardiovasc Drugs Ther       Date:  2021-04-15       Impact factor: 3.947

Review 8.  Therapeutic genome editing in cardiovascular diseases.

Authors:  Masataka Nishiga; Lei S Qi; Joseph C Wu
Journal:  Adv Drug Deliv Rev       Date:  2020-02-21       Impact factor: 15.470

9.  Preclinical techniques to investigate exercise training in vascular pathophysiology.

Authors:  Gurneet S Sangha; Craig J Goergen; Steven J Prior; Sushant M Ranadive; Alisa M Clyne
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-01-01       Impact factor: 5.125

Review 10.  Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models.

Authors:  Sara Gargiulo; Matteo Gramanzini; Marcello Mancini
Journal:  Int J Mol Sci       Date:  2016-09-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.